Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: phase 1 outcomes from the CATIE-AD effectiveness trial (Q37271450)
Jump to navigation
Jump to search
scientific article published on 02 June 2008
Language | Label | Description | Also known as |
---|---|---|---|
English | Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: phase 1 outcomes from the CATIE-AD effectiveness trial |
scientific article published on 02 June 2008 |
Statements
1 reference
Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: phase 1 outcomes from the CATIE-AD effectiveness trial (English)
1 reference
Robert A Rosenheck
1 reference
Constantine G Lyketsos
1 reference
Jeffrey A Lieberman
1 reference
David L Sultzer
1 reference
Sonia M Davis
1 reference
Pierre N Tariot
1 reference
Karen S Dagerman
1 reference
Barry D Lebowitz
1 reference
John K Hsiao
1 reference
Lon S Schneider
1 reference
CATIE-AD Study Group
1 reference
2 June 2008
1 reference
1 reference
844-854
1 reference
Identifiers
1 reference
1 reference
1 reference